Exalamide

This classification denotes an antifungal agent with the molecular formula C13H19NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7JEC65JCG2, chemically known as benzamide, o-hexyloxy- but generally known as exalamide, which bears US NIH Compound Identifier 3316. European Medicines Agency schedules Exalamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07354MIG. The term EXALAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). EXALAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule exalamide under HS 29242995 and SITC 51479. As of Q4 2014, EXALAMIDE remains the US FDA Preferred Term for this commodity. Exalamide bears US NLM identifiers UMLS ID C0046146 and NCI Concept Code C65607. SMILES: O(CCCCCC)C1C(CCCC1)C(=O)N.